Vaccines

The COVID-19 vaccines demonstrate what’s possible when disease is tackled as a genuine priority.

What have we learned from the pandemics of the past? Experts give their view in a video discussion.

What have we learned from the pandemic and how can we address the coming challenges?

In this video roundtable, experts discuss the COVID-19 pandemic and the progress made so far.

The UK approves Pfizer/BioNTech’s COVID-19 vaccine for emergency use.

There is a promising pipeline of vaccine candidates, but what happens if the frontrunners fail?

Sitting Down With… Elaine O’Hara, Chief Commercial Officer at Sanofi Pasteur.

Never before has the industry moved so rapidly to find new treatments and vaccines – but safety and efficacy must remain top priorities.

What lies beyond COVID-19? There are many diseases that could benefit from all the collaborative effort and funding being poured into COVID-19.

A look at the past, present, and future of vaccine production – and how COVID-19 changes the outlook.